{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:59:30Z","timestamp":1781571570386,"version":"3.54.5"},"reference-count":63,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Background: Heart failure (HF) and atrial fibrillation (AF) commonly coexist and patients with both diseases have a worse prognosis than those with HF or AF alone. The objective of our study was to identify the factors associated with one-year mortality in patients with HF and AF, depending on the left ventricular ejection fraction (LVEF). Methods: We included 727 patients with HF and AF consecutively admitted in a clinical emergency hospital between January 2018 and December 2019. The inclusion criteria were age of more than 18 years, diagnosis of chronic HF and AF (paroxysmal, persistent, permanent), and signed informed consent. The exclusion criteria were the absence of echocardiographic data, a suboptimal ultrasound view, and other cardiac rhythms than AF. The patients were divided into 3 groups: group 1 (337 patients with AF and HF with reduced ejection fraction (HFrEF)), group 2 (112 patients with AF and HF with mid-range ejection fraction (HFmrEF)), and group 3 (278 patients with AF and HF with preserved ejection fraction (HFpEF)). Results: The one-year mortality rates were 36.49% in group 1, 27.67% in group 2, and 27.69% in group 3. The factors that increased one-year mortality were chronic kidney disease (OR 2.35, 95% CI 1.45\u20133.83), coronary artery disease (OR 1.67, 95% CI 1.06\u20132.62), and diabetes (OR 1.66, 95% CI 1.05\u20132.67) in patients with HFrEF; and hypertension in patients with HFpEF (OR 2.45, 95% CI 1.36\u20134.39). Conclusions: One-year mortality in patients with HF and AF is influenced by different factors, depending on the LVEF.<\/jats:p>","DOI":"10.3390\/healthcare9070830","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T02:44:39Z","timestamp":1625107479000},"page":"830","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Comorbidities Associated with One-Year Mortality in Patients with Atrial Fibrillation and Heart Failure"],"prefix":"10.3390","volume":"9","author":[{"given":"Ruxandra Nicoleta","family":"Horodinschi","sequence":"first","affiliation":[{"name":"Department 5, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Internal Medicine, Clinical Emergency Hospital of Bucharest, 014461 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6837-260X","authenticated-orcid":false,"given":"Camelia Cristina","family":"Diaconu","sequence":"additional","affiliation":[{"name":"Department 5, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Internal Medicine, Clinical Emergency Hospital of Bucharest, 014461 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,1]]},"reference":[{"key":"ref_1","first-page":"352","article-title":"Universal definition and classification of heart failure: A report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of the atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery","volume":"42","author":"Hindricks","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/europace\/eur081","article-title":"What are the costs of heart failure?","volume":"13","author":"Braunschweig","year":"2011","journal-title":"Europace"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jval.2011.09.009","article-title":"A review of the cost of atrial fibrillation","volume":"15","author":"Wodchis","year":"2012","journal-title":"Value Health"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial fibrillation begets heart failure and vice versa","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1161\/CIRCHEARTFAILURE.111.962688","article-title":"Atrial fibrillation and mortality in heart failure: A community study","volume":"4","author":"Chamberlain","year":"2011","journal-title":"Circ. Heart Fail."},{"key":"ref_7","first-page":"317","article-title":"Update for 2014 on Clinical Cardiology, Geriatric Cardiology, and Heart Failure and Transplantation","volume":"68","author":"Manito","year":"2015","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_8","first-page":"31","article-title":"Short- and Long-term Prognosis of Previous and New-onset Atrial Fibrillation in ST-segment Elevation Acute Myocardial Infarction","volume":"68","year":"2015","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"i4482","DOI":"10.1136\/bmj.i4482","article-title":"Atrial fibrillation and risks of cardiovascular disease, renal disease, and death: Systematic review and meta-analysis","volume":"354","author":"Odutayo","year":"2016","journal-title":"BMJ"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.amjmed.2016.06.045","article-title":"Causes od death and influencing factors in patients with atrial fibrillation","volume":"129","author":"Fauchier","year":"2016","journal-title":"Am. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1093\/eurheartj\/ehm308","article-title":"Increased mortality in paroxysmal atrial fibrillation: Report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF)","volume":"28","author":"Friberg","year":"2007","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/eurheartj\/ehs469","article-title":"All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995\u20132008: A Swedish nationwide long-term case-control study","volume":"34","author":"Andersson","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1177\/2047487316674830","article-title":"Atrial fibrillation in New Zealand primary care: Prevalence, risk factors for stroke and the management of thromboembolic risk","volume":"24","author":"Tomlin","year":"2017","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pharmthera.2016.10.019","article-title":"Atrial fibrillation in heart failure with preserved ejection fraction: Insights into mechanisms and therapeutics","volume":"176","author":"Patel","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.amjmed.2014.06.006","article-title":"New-onset atrial fibrillation predicts heart failure progression","volume":"127","author":"Aleong","year":"2014","journal-title":"Am. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ahj.2003.07.021","article-title":"The expanding national burden of heart failure in the United States: The influence of heart failure in women","volume":"14","author":"Koelling","year":"2004","journal-title":"Am. Heart J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Fonarow","year":"2005","journal-title":"Am. Heart J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jchf.2016.10.005","article-title":"Atrial Fibrillation in Heart Failure with Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume","volume":"5","author":"Lam","year":"2017","journal-title":"JACC Heart Fail."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjmed.2009.06.033","article-title":"Atrial fibrillation in heart failure: A comprehensive review","volume":"123","author":"Deedwania","year":"2010","journal-title":"Am. J. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1161\/01.CIR.0000072767.89944.6E","article-title":"Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham heart study","volume":"107","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"ref_21","first-page":"4593","article-title":"Relationship between atrial fibrillation and heart failure","volume":"20","author":"Hu","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pcad.2015.07.004","article-title":"Atrial fibrillation and heart failure: Update 2015","volume":"58","author":"Thihalolipavan","year":"2015","journal-title":"Prog. Cardiovasc Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.jacc.2006.01.060","article-title":"Atrial fibrillation and risk of clinical events in chronic heart failure with and without left ventricular systolic dysfunction","volume":"47","author":"Olsson","year":"2006","journal-title":"J. Am. Coll Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.eupc.2004.07.003","article-title":"Atrial fibrillation and heart failure: Natural history and pharmacological treatment","volume":"5","author":"Savelieva","year":"2004","journal-title":"Europace"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/eurjhf\/hfp085","article-title":"A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure","volume":"11","author":"Mamas","year":"2009","journal-title":"Eur. J. Heart Fail."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1445-5994.2009.01991.x","article-title":"Atrial fibrillation and the risk of death in patients with heart failure: A literature-based meta-analysis","volume":"40","author":"Wasywich","year":"2010","journal-title":"Intern. Med. J."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.36628\/ijhf.2020.0004","article-title":"Sex and Gender Differences in Heart Failure","volume":"2","year":"2020","journal-title":"Int. J. Heart Fail."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e018574","DOI":"10.1161\/JAHA.120.018574","article-title":"Sex differences in heart failure with preserved ejection fraction","volume":"10","author":"Sotomi","year":"2021","journal-title":"JAHA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jchf.2019.01.004","article-title":"Sex differences in heart failure with preserved ejection fraction pathophysiology","volume":"7","author":"Beale","year":"2019","journal-title":"JACC Heart Fail."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijcard.2017.10.068","article-title":"Sex-related differences in chronic heart failure","volume":"255","author":"Aimo","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1161\/CIRCULATIONAHA.106.673442","article-title":"Sex differences in clinical characteristics and prognosis in a broad spectrum of patients with heart failure: Results of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program","volume":"115","author":"Clayton","year":"2007","journal-title":"Circulation"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1692104","DOI":"10.1155\/2019\/1692104","article-title":"Predictors of unfavourable outcomes in patients with atrial fibrillation and concomitant heart failure with different ejection fractions: RIF-CHF Register one-year follow-up","volume":"2019","author":"Zhirov","year":"2019","journal-title":"Cardiol. Res. Pract."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/euhj.1999.2107","article-title":"Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure","volume":"21","author":"Crijins","year":"2000","journal-title":"Eur. Heart J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1136\/heartjnl-2019-316219","article-title":"impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction","volume":"106","author":"Son","year":"2020","journal-title":"Heart"},{"key":"ref_35","first-page":"15","article-title":"Hypertension and heart failure with preserved ejection fraction: Connecting the dots","volume":"16","author":"Tsioufis","year":"2018","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11906-017-0709-2","article-title":"Current perspectives on systemic hypertension in heart failure with preserved ejection fraction","volume":"19","author":"Tam","year":"2017","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jacc.2005.10.055","article-title":"Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction. Predictive role of C-Reactive protein","volume":"47","author":"Suleiman","year":"2006","journal-title":"J. Am. Coll Cardiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0735-1097(01)01700-4","article-title":"Confirmation of a heart failure epidemic: Findings from the Resource Utilization Among Congestive Heart Failure (REACH) study","volume":"39","author":"McCullough","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1056\/NEJMoa1602001","article-title":"Coronary-artery bypass surgery in patients with ischemic cardiomyopathy","volume":"374","author":"Velazquez","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"e003255","DOI":"10.1161\/CIRCHEARTFAILURE.116.003255","article-title":"Survival benefits of invasive versus conservative strategies in heart failure in patients with reduced ejection fraction and coronary artery disease","volume":"10","author":"Wolff","year":"2017","journal-title":"Circ. Heart Fail."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Hill, N.R., Fatoba, S.T., Oke, J.L., Hirst, J.A., O\u2019Callaghan, C.A., Lasserson, D.S., and Hobbs, F.D.R. (2016). Global prevalence of chronic kidney disease\u2014a systematic review and meta-analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0158765"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ahj.2004.03.042","article-title":"Slowing the progression of diabetic nephropathy and its cardiovascular consequences","volume":"148","author":"McCullough","year":"2004","journal-title":"Am. Heart J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.kint.2019.02.022","article-title":"Heart failure in chronic kidney disease: Conclusions from a kidney disease: Improving global outcomes (KIDGO) controversies conference","volume":"95","author":"House","year":"2019","journal-title":"Kidney Int."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1161\/CIRCOUTCOMES.113.000221","article-title":"Chronic kidney disease andoutcomes in heart failure with preserved versus reduced ejection fraction: The Cardiovascular Research Network PRESERVE Study","volume":"6","author":"Smith","year":"2013","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/CIRCULATIONAHA.105.580506","article-title":"Renal function as a predictor ofoutcome in a broad spectrum of patients with heart failure","volume":"113","author":"Hillege","year":"2006","journal-title":"Circulation"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1525-139X.2011.01011.x","article-title":"Diastolic heart failure in dialysis patients: Mechanisms, diagnostic approach, and treatment","volume":"25","author":"Bucharles","year":"2012","journal-title":"Semin. Dial."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Segall, L., Nistor, I., and Covic, A. (2014). Heart failure in patients with chronic kidney disease: A systematic integrative review. Biomed. Res. Int., 937398.","DOI":"10.1155\/2014\/937398"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/ki.2009.35","article-title":"Left ventricular hypertrophy in renal disease: Beyond preload and afterload","volume":"75","author":"Ritz","year":"2009","journal-title":"Kidney Int."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1525-139X.2008.00454.x","article-title":"Hypertrophy and fibrosis in the cardiomyopathy of uremia\u2014Beyond coronary heart disease","volume":"21","author":"Gross","year":"2008","journal-title":"Semin. Dial."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2215\/CJN.04571007","article-title":"The challenge of sudden death in dialysis patients","volume":"3","author":"Ritz","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/ejhf.821","article-title":"Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction","volume":"19","author":"Lofman","year":"2017","journal-title":"Eur. J. Heart Fail."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.15420\/cfr.2016:20:2","article-title":"Heart failure in patients with diabetes mellitus","volume":"3","author":"Rosano","year":"2017","journal-title":"Card. Fail Rev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"76","DOI":"10.2459\/JCM.0b013e32834058d1","article-title":"Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure","volume":"12","author":"Metra","year":"2011","journal-title":"J. Cardiovasc. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.37358\/RC.18.11.6730","article-title":"Heart failure with preserved ejection fraction and atrial fibrillation: A review","volume":"69","author":"Manea","year":"2018","journal-title":"Rev. Chim."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.2174\/138161211798357773","article-title":"Optimization of cardiac metabolism in heart failure","volume":"17","author":"Nagoshi","year":"2011","journal-title":"Curr. Pharm. Des."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: An analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"ACCORD Study Group, Gerstein, H.C., Miller, M.E., Genuth, S., Ismail-Beigi, F., Buse, J.B., Goff, D.C., Probstfield, J.L., Cushman, W.C., and Ginsberg, H.N. (2011). Long-term effects of intensive glucose lowering on cardiovascular outcomes. N. Engl. J. Med., 364, 818\u2013828.","DOI":"10.1056\/NEJMoa1006524"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"d4169","DOI":"10.1136\/bmj.d4169","article-title":"Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: Meta-analysis of randomised controlled trials","volume":"343","author":"Boussageon","year":"2011","journal-title":"BMJ"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/ejhf.455","article-title":"Mean HbA1c and mortality in diabetic individuals with heart failure: A population cohort study","volume":"18","author":"Elder","year":"2016","journal-title":"Eur. J. Heart Fail."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/9\/7\/830\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:24:29Z","timestamp":1760163869000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/9\/7\/830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,1]]},"references-count":63,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7]]}},"alternative-id":["healthcare9070830"],"URL":"https:\/\/doi.org\/10.3390\/healthcare9070830","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,1]]}}}